Journals / Türk Oftalmoloji Dergisi / 2021 / Cilt: 51 - Sayı: 3

Ocular Findings of Pediatric Dry Eye Related to Graft-Versus-Host Disease

Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular

Pages
134–138
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, these patients should be examined periodically for dry eye.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To evaluate the frequency and findings of dry eye associated with ocular graft-versus-host disease (GVHD) in pediatric hematopoietic stem cell transplantation (HSCT) patients.
📊
Key Findings & Data:Results: GVHD was detected in 51 (23.4%) of 218 HSCT patients, 4 of whom died during follow-up.
💡
Conclusion & Impact:Therefore, these patients should be examined periodically for dry eye.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To evaluate the frequency and findings of dry eye associated with ocular graft-versus-host disease (GVHD) in pediatric hematopoietic stem cell transplantation (HSCT) patients. Materials and Methods: Retrospectively the records of pediatric patients with ocular GVHD were evaluated and ophthalmologic examination findings as well as Schirmer test results, tear film break-up time, and corneal staining grades were recorded. In severe dry eye patients topical cyclosporine-A was prescribed and the results were evaluated. Results: GVHD was detected in 51 (23.4%) of 218 HSCT patients, 4 of whom died during follow-up. Thirty (63.8%) of the remaining 47 patients had chronic ocular GVHD and 4 patients with severe dry eye were treated with topical cyclosporine-A with a median follow-up of 12.1 months. Severe dry eye symptoms and findings significantly improved in 2 patients. However, 1 patient had to stop treatment due to side effects. Conclusion: In children, chronic ocular GVHD is a common finding of GVHD after HSCT. Therefore, these patients should be examined periodically for dry eye.

Özet

Amaç: Pediatrik hematopoetik kök hücre nakli (HKHN) yapılan hastalarda gelişen oküler graft versus host hastalığının (GVHH) sıklığını ve bulgularını incelemek. Gereç ve Yöntem: Oküler GVHH tanısı alan pediatrik hastaların dosyaları retrospektif olarak incelendi ve bu hastaların Schirmer testi, gözyaşı kırılma zamanı ve korneal boyanma derecelenmesini içeren muayene bulguları kaydedildi. Ciddi kuru gözü olan hastalara topikal siklosporin-A başlandı ve tedavinin sonuçları değerlendirildi. Bulgular: HKHN yapılan 218 hastadan 51’inde (%23,4) GVHH tespit edildi ve bu hastaların 4’ü takipleri sırasında hayatını kaybetti. Takip edilen toplam 47 hastanın %63,8’inde kronik oküler GVHH tespit edildi ve 4 hastaya ortanca takip süresi 12,1 ay olmak üzere ciddi kuru göz bulguları nedeniyle topikal siklosporin-A tedavisi uygulandı. İki hastada ciddi kuru göz bulgularında belirgin bir düzelme izlenirken, 1 hastada ilaç yan etkisi nedeniyle tedavinin kesilmesi gerekti. Sonuç: Kronik oküler GVHH, çocuklarda HKHN sonrası gelişen GVHH’nin sık izlenen bir bulgusudur. Bu nedenle, bu hastaların kuru göz açısından belirli aralıkla muayene edilmesi gerekmektedir.

🔖

Cite This Article

YALÇINDAĞ, F. N., ATİLLA, H., BÜYÜKTEPE, T. Ç., KIZILTUNÇ, P. B., İNCE, E., İLERİ, T., ERTEM, M. (2022). Ocular Findings of Pediatric Dry Eye Related to Graft-Versus-Host Disease. Türk Oftalmoloji Dergisi, Cilt: 51 - Sayı: 3, 134–138. https://ajindex.com/articles/637632

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Strocchio L, Locatelli F. Hematopoietic Stem Cell Transplantation in Thalassemia. Hematol Oncol Clin North Am. 2018;32:317-328
  2. Kim H. Treatments for children and adolescents with AML. Blood Res. 2020;55(Suppl 1):5-13
  3. Tan EY, Boelens JJ, Jones SA, Wynn RF. Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism. Front Pediatr. 2019;7:433
  4. Atkinson K. Bone marrow transplantation. Med J Aust. 1992;157:408-411
  5. Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58:233-251
  6. No authors listed. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75-92
  7. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650
  8. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956
  9. Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983;90:4-13
  10. Hirst LW, Jabs DA, Tutschka PJ, Green WR, Santos GW. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol. 1983;101:580-584
  11. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, Fagioli F, Porta F, Favre C, Pession A, Locatelli F; AIEOP-BMT Group. Chronic graftversus- host disease in children: incidence, risk factors, and impact on outcome. Blood 2002;100:1192-1200
  12. Kondo M, Kojima S, Horibe K, Kato K, Matsuyama T. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children. Bone Marrow Transplant. 2001;27:727-730
  13. Eisner MD, August CS. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone Marrow Transplant. 1995;15:663-668
  14. Bray LC, Carey PJ, Proctor SJ, Evans RG, Hamilton PJ. Ocular complications of bone m